Replies to post #225375 on Biotech Values

[DewDiligence]

ABBV-AGN PR on $63B buyout:

https://finance.yahoo.com/news/abbvie-acquire-allergan-transformative-move-104200213.html

Under the terms of the Transaction Agreement, Allergan Shareholders will receive 0.8660 AbbVie Shares and $120.30 in cash for each Allergan…for a total consideration of $188.24 per Allergan Share [based on ABBV’s 6/24/19 closing price]. The transaction represents a 45% premium to the closing price of Allergan's Shares on June 24, 2019.